FOLH1 and posterior cortical atrophy: Another prospective single-center one-arm Phase II clinical trial (ClinicalTrials.gov ID: NCT06259123) evaluates the impact of systemic radioligand therapy with [177Lu]-Lu-PSMA-I&T in patients with oligometastatic PCa scheduled for radical prostatectomy.